About this trial
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ovarian tumor of low malignant potential
Low-grade serous carcinoma of the ovary
Primary peritoneal tumor of low malignant potential
Low-grade serous carcinoma of the peritoneum
Disqualifiers
None
Trial population
Patients with a low-grade tumor of Mullerian origin who sought treatment or a second opinion at MD Anderson Cancer Center (MDACC) at any point in the course of their disease and treatment (beginning in January 1950), and patients currently being treated at MDACC or seeking treatment or a second opinion in the future
Trial design
Cohort
Other
Treatments tested in this trial
Biospecimen Collection
Procedure/SurgeryPatients' residual tissue samples are collected
Electronic Health Record Review
Other interventionMedical records are reviewed
Treatment groups
Trial outcomes
Primary outcomes
Prospective and retrospective data collection on disease characterization, treatment, and outcomes
Organization of clinical information
Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.
Creation of a single data repository to integrate clinical information and research findings
Secondary outcomes
Collection and storage of human tumor samples for the establishment of a tumor bank
Sponsors and contacts
Click on the lead sponsor to view all of their trials.